Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
An enterovirus 71 (EV71) vaccine for the prevention of hand, foot, and mouth disease (HMFD) is available, but it is not known whether the EV71 vaccine cross-protects against Coxsackievirus (CV) infection. Furthermore, although an inactivated circulating CVA16 Changchun 024 (CC024) strain vaccine can...
Main Authors: | L. Huang, X. Liu, J.L. Li, J.L. Chang, G.C. Liu, X.F. Yu, W.Y. Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2015-03-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/pdf/bjmbr/v48n5/1414-431X-bjmbr-1414-431X20144298.pdf |
Similar Items
-
Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor
by: Xueyang Zhang, et al.
Published: (2017-01-01) -
Genetic and Cross Neutralization Analyses of Coxsackievirus A16 Circulating in Taiwan from 1998 to 2021 Suggest Dominant Genotype B1 can Serve as Vaccine Candidate
by: Dayna Cheng, et al.
Published: (2022-10-01) -
Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils
by: Yi-Sheng Sun, et al.
Published: (2022-12-01) -
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine
by: Bopei Cui, et al.
Published: (2021-02-01) -
A case of coxsackievirus A16-induced hand-foot-mouth disease mimicking erythema multiforme
by: Shigeru Koizumi, et al.
Published: (2023-08-01)